Clinical trial NCT06523257: Prevalence of Chronic Obstructive Pulmonary Disease in the Portuguese Population
Official title: Prevalence of Chronic Obstructive Pulmonary Disease in the Portuguese Population- EpiCOPDpt Study
Study type: OBSERVATIONAL
Overall status: NOT_YET_RECRUITING
Conditions: Chronic Obstructive Pulmonary Disease
Lead sponsor: Sociedade Portuguesa de Pneumologia
Sponsor class: OTHER
First posted: 2024-07-26
Enrollment: 8589
Sex: ALL
Minimum age (years): 20
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: ECOLOGIC_OR_COMMUNITY
Time perspective: CROSS_SECTIONAL
Sampling method: PROBABILITY_SAMPLE
Study population: Portuguese population aged 20 years and over.

Brief summary: The EpiCOPDpt Study (Prevalence of Chronic Obstructive Pulmonary Disease in the Portuguese Population) primary objective is to estimate the prevalence of Chronic Obstructive Pulmonary Disease (COPD) in the Portuguese population aged 20 and over. It is a cross-sectional study of a representative sample of the Portuguese population aged 20 and over, using standardised post-bronchodilator spirometry. Questionnaires will be applied to collect sociodemographic, economic, clinical, and therapeutic data.


Eligibility criteria: Inclusion Criteria:

* Male and female subjects aged 20 years and over, with permanent or temporary residence for at least one year in the national territory;
* Written informed consent for study participation.

Exclusion Criteria:

* Any condition that makes it impossible to perform spirometry, in accordance with standards of the joint American Thoracic Society/European Respiratory Society, and as described in the "Contraindications for spirometry testing" section of the Study Procedures Manual;
* Any condition that makes it impossible to perform the bronchodilation, as described in the "Contraindications for bronchodilation" section of the Study Procedures Manual;
* Severe cognitive disability that may interfere with the person's capability to participate in the study.

Primary outcomes:
measure: Individuals aged 20 years and over in the Portuguese population diagnosed with COPD(Chronic Obstructive Pulmonary Disease).
timeFrame: Through study completion, an average of 10 months
Secondary outcomes:
measure: Individuals aged 20 years and over in the Portuguese population diagnosed with COPD (Chronic Obstructive Pulmonary Disease), by age group
timeFrame: Through study completion, an average of 10 months
measure: Individuals aged >20 years in the Portuguese population diagnosed with COPD (Chronic Obstructive Pulmonary Disease) by sex
timeFrame: Through study completion, an average of 10 months
measure: Individuals diagnosed with COPD (Chronic Obstructive Pulmonary Disease) in each NUTS region
timeFrame: Through study completion, an average of 10 months
measure: Sociodemographic profile of respiratory patients
timeFrame: Through study completion, an average of 10 months
measure: Clinical profile of respiratory patients
timeFrame: Through study completion, an average of 10 months
measure: Risk profile of participants
timeFrame: Through study completion, an average of 10 months
Other outcomes:
Locations:
Study officials:
References: